RUSH’s Advanced Diagnostic and Treatment Options for Prostate Cancer with Edward Cherullo, MD

Clinicians in the RUSH Department of Urology are some of the country’s leading laparoscopic and robotic surgeons who offer patients the most advanced diagnostic capabilities for diagnosing urologic cancers, including prostate cancer. Once a timely, accurate diagnosis has been made, RUSH urologists create tailored treatment plans that leverage leading-edge treatments to improve patient outcomes and their quality of life.

Edward Cherullo, MD, is a urologist and the chief of the Department of Urology at RUSH University Medical Center. Under his leadership, Dr. Cherullo has expanded the Department’s efforts to provide comprehensive subspeciality care that incorporates the latest minimally invasive technologies. As a result, the Department of Urology is a regional and national leader of urologic care and is currently ranked No. 14 in the country by U.S. News & World Report.

“Prostate cancer is a very infiltrative cancer, which can be invisible on CT scan and even standard MRI. The advanced diagnostic technologies we use allow us to see the prostate gland in detail, including some of its metabolic activity and the cancer with 85 to 90% accuracy, which is good. That accuracy helps us make more accurate decisions regarding treatment.”

CME link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/487011/